hydroxyurea has been researched along with Lupus Erythematosus, Systemic in 4 studies
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nine patients with systemic lupus erythematosus had increased percentages of these cells in the synthesis and postsynthesis phases of the cell cycle; the B lymphocyte had a greatest proportions of activated cells." | 1.26 | Abnormalities in the content of nucleic acids of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. ( Alarcón-Segovia, D; Díaz-Jouanen, E; Fishbein, E; Llorente, L, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Michel, M | 1 |
| Habibi, A | 1 |
| Godeau, B | 1 |
| Bachir, D | 1 |
| Lahary, A | 1 |
| Galacteros, F | 1 |
| Fifi-Mah, A | 1 |
| Arfi, S | 1 |
| Alarcón-Segovia, D | 1 |
| Llorente, L | 1 |
| Fishbein, E | 1 |
| Díaz-Jouanen, E | 1 |
| Hackshaw, KV | 1 |
| Shi, Y | 1 |
| Brandwein, SR | 1 |
| Jones, K | 1 |
| Westcott, JY | 1 |
| Layton, AM | 1 |
| Cotterill, JA | 1 |
| Tomlinson, IW | 1 |
1 trial available for hydroxyurea and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
A pilot study of zileuton, a novel selective 5-lipoxygenase inhibitor, in patients with systemic lupus erythematosus.
Topics: Adult; Aged; Double-Blind Method; Female; Humans; Hydroxyurea; Leukotriene Antagonists; Leukotriene | 1995 |
3 other studies available for hydroxyurea and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Characteristics and outcome of connective tissue diseases in patients with sickle-cell disease: report of 30 cases.
Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Arthritis, Rheumatoid; Blood Transfusion; Drug Ther | 2008 |
Abnormalities in the content of nucleic acids of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Topics: Antibodies; Antibodies, Antinuclear; B-Lymphocytes; Blood Cells; Cell Cycle; DNA; Female; Humans; Hy | 1982 |
Hydroxyurea-induced lupus erythematosus.
Topics: Female; Humans; Hydroxyurea; Lupus Erythematosus, Systemic; Middle Aged; Psoriasis | 1994 |